Self-efficacy, cancer-related fatigue, and quality of life in patients with resected lung cancer

Chen, Honglin; Liu, Kun; You, Qingsheng

doi:10.1111/ecc.12934

Cited by 39 publications

(31 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Among the siblings however, self-efficacy was associated only with the HRQoL parameters general health and mental health. The findings are supported by previous research investigating quality of life and self-efficacy in adult cancer patients [ 41 , 42 ]. Social support showed to be of importance among both YA ALL survivors and the siblings regarding general health, vitality, mental health and depression.…”

Section: Discussionsupporting

confidence: 88%

Health related quality of life and buffering factors in adult survivors of acute pediatric lymphoblastic leukemia and their siblings

Aili

Arvidsson

Nygren

2021

Health Qual Life Outcomes

View full text Add to dashboard Cite

Background The improvement in treatment of pediatric acute lymphatic leukemia (ALL) has introduced new challenges for pediatric oncology care in understanding and handling long-term treatment-related complications later in adult life. The aim of this study was to describe health related quality of life (HRQoL) and the relation to buffering factors among young adult (YA) pediatric ALL survivors and their siblings. Methods This cross-sectional study was performed among 227 adults, treated for pediatric ALL in Sweden between 1985 and 1997 and their siblings (n = 70). Group means of HRQoL (SF-36) were compared between YA ALL survivors and the siblings, as well as to normative values from the general population. Self-efficacy (GSES) and social support (SS-13 subscale AVSI) was considering potential buffering factors for HRQoL and mental health. Associations between HRQoL and mental health respectively and self-efficacy and social support was analyzed. Results The YA ALL survivors scored significantly lower on the HRQoL parameters general health (69.6 vs. 78.4, p = 0.004) and role emotional (77.1 vs. 88.1, p = 0.014), than the siblings. Further, they reported significantly lower general health (69.6 vs. 75.8), vitality (56.9 vs. 68.8), social functioning (84.5 vs. 88.6), role emotional (77.1 vs. 85.7) and mental health (71.3 vs. 80.9) compared with Swedish norms. Both YA ALL survivors and the siblings reported lower vitality and worse mental health than the general population. The HRQoL parameters, depression, stress and anxiety were all associated with both self-efficacy and social support among the YA ALL survivors. Among the siblings however, only general health, vitality, role emotional, mental health and depression were associated with social support, and only general health and mental health were associated with general self-efficacy. Conclusion The results from this study show that buffering factors, like social support and self-efficacy, may play an important role for psychosocial outcomes and HRQoL among YA ALL survivors later in life. The results suggest that this group could benefit from continuous support in adult life to handle consequences of their pediatric disease.

show abstract

Section: Discussionsupporting

confidence: 88%

Health related quality of life and buffering factors in adult survivors of acute pediatric lymphoblastic leukemia and their siblings

Aili

Arvidsson

Nygren

2021

Health Qual Life Outcomes

View full text Add to dashboard Cite

show abstract

“…The possible reasons might involve that (1) According to existing evidence, reminiscence therapy could improve the self-efficacy and problem-solving ability, which could make up for the deficiency caused by cancer-related functional impairments and further promote QoL in post-operational NSCLC patients. [20][21][22] (2) On the basis of previous findings in our present study, RTCP could promote mental health in NSCLC patients, and considering that depression and anxiety were risk factors for QoL, RTCP might improve QoL indirectly via positively affecting mental status of post-operational NSCLC patients. Interestingly, the results in our study demonstrated that there existed a numerical decreased longitudinal trend in rate and severity of anxiety and depression in RTCP group from M0 to M12, which also implied the effect of RTCP in post-operational NSCLC patients.…”

Section: Discussionmentioning

confidence: 61%

“…In current study, we observed that RTCP exhibited better effect on improving QoL compared with CCP in post‐operational NSCLC patients. The possible reasons might involve that (1) According to existing evidence, reminiscence therapy could improve the self‐efficacy and problem‐solving ability, which could make up for the deficiency caused by cancer‐related functional impairments and further promote QoL in post‐operational NSCLC patients 20‐22 . (2) On the basis of previous findings in our present study, RTCP could promote mental health in NSCLC patients, and considering that depression and anxiety were risk factors for QoL, RTCP might improve QoL indirectly via positively affecting mental status of post‐operational NSCLC patients.…”

Section: Discussionmentioning

confidence: 74%

Reminiscence therapy‐based care program relieves anxiety, depression, and improves quality of life in post‐operational non‐small cell lung cancer patients

Liu

2021

Clinical Respiratory J

View full text Add to dashboard Cite

Objectives The study aimed to explore the effect of reminiscence therapy‐based care program (RTCP) on anxiety, depression, quality of life (QoL), and survival profiles in post‐operational non‐small cell lung cancer (NSCLC) patients. Methods In this randomized, controlled study, a total of 192 newly diagnosed post‐operational NSCLC patients were randomly assigned to control care program (CCP) group (N = 96) or RTCP group (N = 96), and both groups experienced 12‐month intervention and 36‐month follow‐up without intervention. Hospital Anxiety and Depression Scale (HADS) and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ‐C30) were evaluated at baseline (M0), month (M)3, M6, and M12. Results Reduced HADS‐anxiety score at M6 and M12, anxiety rate at M12, and anxiety severity at M6 and M12 were observed in RTCP group compared with CCP group. Additionally, HADS‐depression score was decreased at M6 and M12, while both depression rate and severity were of no difference at each time point between two groups. Furthermore, QLQ‐C30 global health status score at M6 and M12, QLQ‐C30 functions score at M12 were increased, while QLQ‐C30 symptoms score was of no difference at each time point in RTCP group compared with CCP group. Regarding survival profiles, Kaplan–Meier curves indicated that disease‐free survival and overall survival were of no difference between two groups, further multivariate Cox’s proportional hazard regression analysis also observed the same trends. Conclusion RTCP effectively relieves anxiety and depression, improves QoL, but did not prolong survival, suggesting its value as a non‐pharmacological approach for post‐operational NSCLC management.

show abstract

“…Additionally, insomnia, dyspnea, and cough in patients with lung cancer receiving chemotherapy can also affect CRF (Long, Thanasilp, & Thato, 2016). This persistent symptom significantly reduces the quality of life (QOL) in patients with lung cancer (Chen, Liu, & You, 2018; Molassiotis, Lowe, Blackhall, & Lorigan, 2011). Although the underlying pathophysiology of this condition remains unclear, it could be attributed to the outcome of cancer itself and/or the side effects of chemotherapy and radiation therapy (Hofman, Ryan, Figueroa‐Moseley, Jean‐Pierre, & Morrow, 2007).…”

Section: Introductionmentioning

confidence: 99%

Effectiveness and safety of herbal medicine for cancer‐related fatigue in lung cancer survivors: A systematic review and meta‐analysis

Kwon

Lee

Kong

et al. 2020

Phytotherapy Research

View full text Add to dashboard Cite

Approximately half of lung cancer patients (LCP) receiving chemotherapy are experiencing cancer‐related fatigue (CRF). In East Asia, herbal medicines (HMs) have been used as tonics due to their anti‐fatigue effect. This systematic review evaluated the effectiveness and safety of HMs for CRF in LCP. We comprehensively searched 12 electronic medical databases to search randomized controlled trials (RCTs) and quasi‐RCTs investigating HMs for CRF in LCP, published up to September 2019. The primary outcome was the fatigue severity. Secondary outcomes included patients' quality of life (QOL), activities of daily life (ADL), and incidence of adverse events. Cochrane's risk of bias tool assessed the methodological quality of included RCTs. The risk ratio or mean difference was estimated with 95% confidence intervals by performing a meta‐analysis. Twelve RCTs with 861 participants were included. Compared to conventional medicine alone, HM combined with conventional medicine significantly improved fatigue level, QOL, and ADL. As monotherapy, HM significantly improved ADL compared with megestrol. No serious HM‐related adverse events were reported. Limited evidence suggests that HM could be effective and safe for CRF in LCP. However, further high‐quality RCTs are needed to confirm these findings owing to the small number and low methodological quality of the included studies.

show abstract

Self-efficacy, cancer-related fatigue, and quality of life in patients with resected lung cancer

Cited by 39 publications

References 27 publications

Health related quality of life and buffering factors in adult survivors of acute pediatric lymphoblastic leukemia and their siblings

Health related quality of life and buffering factors in adult survivors of acute pediatric lymphoblastic leukemia and their siblings

Reminiscence therapy‐based care program relieves anxiety, depression, and improves quality of life in post‐operational non‐small cell lung cancer patients

Effectiveness and safety of herbal medicine for cancer‐related fatigue in lung cancer survivors: A systematic review and meta‐analysis

Contact Info

Product

Resources

About